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Background: Neurological complications are common after orthotopic liver transplantation
(OLT). We aimed to characterize the risk factors associated with neurological complications
and mortality among patients who underwent OLT in the post-model for end-stage liver
disease (MELD) era.
Methods: In a retrospective review, we evaluated 227 consecutive patients at the Keck
Hospital of the University of Southern California before and after OLT to define the type
and frequency of and risk factors for neurological complications and mortality.
Results: Neurological complications were common (n=98), with encephalopathy being
most frequent (56.8%), followed by tremor (26.5%), hallucinations (11.2%), and seizure
(8.2%). Factors associated with neurological complications after OLT included preoperative
dialysis, hepatorenal syndrome, renal insufficiency, intra-operative dialysis, preoperative
encephalopathy, preoperative mechanical ventilation, and infection. Preoperative infection
was an independent predictor of neurological complications (OR 2.83, 1.47–5.44). One-
month mortality was 8.8% and was independently associated with urgent re-transplant,
preoperative intubation, and intra-operative arrhythmia.
Conclusion: Neurological complications are common in patients undergoing OLT in the
post-MELD era, with encephalopathy being most frequent. An improved understanding of
the risk factors related to both neurological complications and one-month mortality post-
transplantation can better guide perioperative care and help improve outcomes among OLT
patients.
Keywords: liver transplant, neurological complications, mortality
INTRODUCTION
Orthotopic liver transplantation (OLT) is the only definitive treat-
ment for end-stage liver disease and is being performed with
increasing frequency in the United States (1). Post-operative
complications after OLT are a significant source of morbidity
and mortality (2, 3), with neurological complications such as
encephalopathy, akinetic mutism, seizures, and stroke reportedly
occurring in 8% to as high as 75% of cases, often within 30 days
of transplantation (4–7). Neurological complications occur more
commonly after OLT than after other solid organ transplanta-
tions such as heart and kidney (8), and studies have suggested that
these higher rates are related to preoperative hepatic encephalopa-
thy, the unfavorable clinical condition of patients awaiting trans-
plantation (e.g., malnutrition, renal insufficiency, hyponatremia,
coagulopathy), and the complexity of the operation (9). Post-
operatively, patients with neurological complications may become
less compliant with immunosuppressive medications, increas-
ing the risk of rejection and graft loss (10, 11). Research has
demonstrated that patients with neurological complications after
OLT have longer hospitalizations and increased rates of infection,
re-transplantation, and mortality (12, 13).
Defining the risk factors for neurological complications and
one-month mortality after OLT can help identify high-risk
patients and guide perioperative care with the intention to mini-
mize neurological complications, morbidity, and mortality. Iden-
tifying primary risk factors is particularly relevant given the high
acuity recipients in the post-model for end-stage liver disease
(MELD) era, as the MELD system prioritizes the allocation of
organs to patients with the most severe liver disease (14). Studies
have suggested that neurological complications can be attributed
to factors such as cerebral infarction, a poorly functioning allo-
graft, intracranial hemorrhage, infection, or immunosuppressant
toxicity (15).
While complications after OLT have been described previ-
ously (15), risk factors for post-operative neurological compli-
cations and one-month mortality are not well-characterized. In
this study, we defined the type and frequency of neurologi-
cal complications in patients who underwent OLT in the post-
MELD era. We identified hypothesis-generating pre-operative and
intra-operative risk factors for neurological complications and
one-month mortality to help improve future patient outcomes
after OLT.
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MATERIALS AND METHODS
DATASET AND STUDY POPULATION
We reviewed the hospital records of 227 consecutive cases of adults
who underwent OLT between July 18, 2003 and August 19, 2006
at the Keck Hospital of the University of Southern California. A
standardized form was used to collect demographic, historical,
surgical, laboratory and radiological data. Data was collected for
the period beginning one week prior to transplant and extend-
ing to one month post-transplant. The Institutional Review Board
approved the study.
Transplants were characterized as partial living donor or cadav-
eric and as first transplant, urgent re-transplant (performed≤ one
month from initial transplant), non-urgent re-transplant (per-
formed> one month from initial transplant), transfusion free, and
simultaneous liver-kidney transplant. MELD scores were calcu-
lated on the day of transplant and included exception points where
applicable in cases of hepatocellular carcinoma. Operating room
records were reviewed for intra-operative events, surgery duration,
pressors used, and hypotension (defined as systolic blood pres-
sure< 90 mmHg). For re-transplants, preoperative data, labs, and
intra-operative records from the first transplant were recorded.
Neurological complications were identified by chart review by the
study’s investigators, including resident physicians and attending
physicians in the Department of Neurology. These complications
were then confirmed by the study’s multiple board certified neu-
rologist investigators. These complications were defined as new
neurological problems or a worsening of known neurological
disorders in one month after OLT. Neurological complications
were further characterized by pre-specified type and date of onset
relative to OLT.
STATISTICAL ANALYSIS
An analysis was done to determine whether neurological com-
plications post-OLT were associated with one-month mortality
post-OLT. Univariate analyses of mortality and neurological com-
plications after OLT were performed using Fisher’s Exact Test and
Wilcoxon Two Sample Test where appropriate, using a p-value
<0.05 threshold for significance. Using a p <0.2 threshold for sig-
nificance, multivariate logistic regression analysis was performed
controlling for potential risk factors for neurologic complica-
tions after OLT; these included medical co-morbidities such as
dialysis and renal insufficiency, preoperative conditions such as
encephalopathy and infection, and intra-operative events such as
dialysis. Six cases were excluded from this analysis due to intra-
operative deaths. A similar multivariate regression analysis was
performed controlling for potential risk factors for one-month
mortality following OLT, such as race, transplant type, medical co-
morbidities, preoperative conditions and intra-operative events,
again using a p< 0.2 threshold.
RESULTS
We identified 228 consecutive adult patients who underwent OLT.
One patient record could not be found, thus 227 patients were
included in the study. Demographic factors are listed in Table 1.
The population was 37% female with a mean age of 52 years and
mostly Hispanic (48.9%) or Caucasian (30.4%). The mean MELD
score was 22 (range from 2 to 40). The most common liver diseases
were hepatocellular carcinoma (20.7%), hepatitis C (19.8%), and
alcohol-induced cirrhosis (15.9%). The majority of transplants
were cadaveric (79.7%) and first-time transplants (94.3%).
NEUROLOGICAL COMPLICATIONS
The one-month incidence of neurological complications was
44.3% (98/221). Sixty-six patients had one neurological com-
plication, 27 had two complications, and five had three compli-
cations. The most common complication was encephalopathy
(53.06%), followed by tremor (27.55%) and seizure (8.16%).
Neurological complications among patients during the first post-
operative month following OLT are summarized in Table 2.
Neurological complications were not associated with one-month
mortality.
Univariate analysis of risk factors for neurological complica-
tions is summarized in Tables 3 and 4. 95% confidence intervals
(CI) for univariate analyses were calculated assuming normal dis-
tribution. Although the MELD score was greater in those with
neurological complications, it was not statistically significant (20
vs. 24, p= 0.06). Medical co-morbidities, such as hepatorenal
syndrome (OR 2.9, 0.87–2.91), renal insufficiency (OR 2.23, 0.93–
2.17), and intra-operative dialysis (OR 1.97, 0.80–2.25) were also
risk factors associated with a greater rate of neurological com-
plications. Furthermore, preoperative use of pressors (OR 2.72,
0.71–3.36), intubation (OR 2.8, 0.78–3.15), and encephalopathy
(OR 1.97, 0.86–2.09) were also factors associated with increased
neurological complications based on the results of the univariate
analysis.
On multivariate analysis, preoperative infection was the only
independent predictor of neurological complications (OR 2.83,
1.49–5.53). There were a total of 50 patients who had preoper-
ative infection, of which 32 (64%) had neurological complica-
tions. The most common neurological complications in this group
were encephalopathy (56.25%) and tremor (21.88%). Exclusion of
intra-operative deaths did not change the study results.
MORTALITY
Overall, one-month mortality was 8.8%. The MELD score was
greater in the mortality group, but not statistically significant (25
vs. 22, p= 0.181). Of the 20 deaths, six occurred intraoperatively
(30%). Characteristics of the 14 mortalities in the study popula-
tion are listed in Table 5. Factors associated with mortality based
on results of the univariate analysis are listed in Tables 6 and
7. 95% CI for univariate analyses were calculated assuming nor-
mal distribution. Preoperative pressor use (OR 4.97, 0.78–5.19)
and infection (OR 3.21, 0.78–3.15) as well as intraoperative car-
diac arrest (OR 55.19, 1.00–32.63) and hypotension (OR 7.78,
0.94–6.34) were associated with greater mortality.
On multivariate analysis, independent predictors of one-month
mortality included urgent re-transplant (OR 13.3, 2.9–55.53), pre-
operative intubation (OR 5.03, 1.54–13.14), and intraoperative
arrhythmia (OR 5.75, 1.56–15.83).
DISCUSSION
The incidence of post-operative neurological complications after
OLT in this study (44%) was comparable to the incidence reported
in the literature of approximately 10–47% (1, 5). Previous studies
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Table 1 | Demographics of patients receiving liver transplant.
Category Characteristics Entire study population,
number (%) (n=227)
No Neurological complications,
number (%) (n=129)
Neurological complications,
number (%) (n=98)
Gender Male 142 (62.6) 74 (57.4) 63 (64.3)
Race Hispanic 111 (48.9) 59 (45.7) 51 (52.0)
Caucasian 69 (30.4) 41 (31.8) 25 (25.5)
Asian 29 (12.8) 15 (11.6) 14 (14.3)
African American 9 (4) 4 (3.1) 5 (5.1)
Other 9 (4) 4 (3.1) 3 (3.1)
Donor type Cadaveric (vs. partial living) 181 (79.7) 94 (72.9) 81 (82.7)
Transplant First transplant 214 (94.3) 110 (85.3) 91 (92.9)
Urgent re-transplant 8 (3.5) 4 (3.1) 4 (4.1)
Non-urgent re-transplant 5 (2) 9 (7.0) 3 (3.1)
Co-transplant None 212 (93.4)
Liver–kidney 15 (6.6) 10 (7.8) 4 (4.1)
Disease etiology Hepatocellular Carcinoma 47 (20.7) 28 (21.7) 18 (18.4)
Hepatitis C 45 (19.8) 36 (27.9) 29 (29.6)
Alcohol 36 (15.9) 19 (14.7) 17 (17.3)
Cryptogenic 16 (7)
Hepatitis B 14 (6.2) 11 (8.5) 3 (3.1)
Autoimmune 10 (4.4)
Primary biliary cirrhosis, fulminant
failure, other
6 (2.6)
Metastasis 3 (1.3)
Alpha 1 antitrypsin, amyloid,
polycystic liver, cholangiocarcinoma,
rejection, sclerosing cholangitis,
Wilson’s
2 (0.9)
have found that most neurological complications usually occur
in the first 3 months after OLT (1). Similar to prior studies, we
focused our study on the first post-operative month (4, 5).
Our results revealed high rates of neurological complications
and mortality after OLT in the post-MELD era. These high rates
of morbidity and mortality may reflect the selection of candi-
dates with more advanced liver disease. The study population had
a mean MELD score of 22, consistent with the reported mean
MELD of 24 in the United Network for Organ Sharing (UNOS)
MELD 2003–2006 database (16).
With improved survival after OLT due to better perioperative
care, operative techniques, and immune suppressive therapy, there
has been increasing awareness of neurological complications (17).
The main neurological complications include encephalopathy,
seizure, immunosuppressant-related neurotoxicity, and periph-
eral nerve damage (1, 18), and the distribution of neurologi-
cal complications in this study is similar to prior reports, with
encephalopathy being the most common (7, 9, 13, 19, 20). Estab-
lished predictors of encephalopathy are alcoholism, metabolic dys-
regulation, MELD> 15, preoperative intubation, and non-elective
liver transplant (21). Our findings demonstrated that neurologi-
cal complications were not associated with one-month mortality.
This lack of independent association suggests that encephalopathy,
the most common neurological complication of this investigation,
may present as a manifestation of other conditions such as infec-
tion or renal failure. Given these findings, the importance of
separately considering encephalopathy when determining post-
operative neurological events and mortality is worthy of additional
study.
The primary aim of this investigation was to evaluate
hypothesis-generating risk factors associated with post-operative
neurological complications. We found that pre-operative infec-
tion was an independent predictor of such complications. Our
study documented any infection in the week prior to surgery,
including bacterial peritonitis and urinary tract infections. None
of the patients who underwent OLT were septic at the time of
surgery. Therefore, it appears that even mild or focal infections
may be associated with an increased susceptibility to neurolog-
ical events. This association is biologically plausible, as bacteria,
viruses, and fungi can spread to the central nervous system just
as they affect the abdomen, blood stream, respiratory tract, and
other organ systems (22). Increases in incidence of encephalopa-
thy and stroke were seen in patients with infection, possibly related
to cerebral and vascular injury from the systemic inflammatory
response. Systemic infection is particularly relevant as bacterial
infections are common during the initial two months after trans-
plantation and negatively affect both graft and patient survival
(23). Transplant patients require high-dose immunosuppression,
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Table 2 | Neurologic complications during the first post-operative
month after OLT.
Complication Cases (n=98)
number (%)
% of total
population (227)
Encephalopathy 52 (53.1) 22.9
Tremor 26 (26.5) 11.5
Hallucination 11 (11.2) 4.8
Seizure 8 (8.2) 3.5
Headache 5 (5.1) 2.2
Intracerebral hemorrhage 5 (5.1) 2.2
Ischemic stroke 5 (5.1) 2.2
Myoclonus 3 (3.1) 1.3
Anxiety 2 (2.0) 0.9
Paresthesia 2 (2.0) 0.9
Dysarthria 2 (2.0) 0.9
Central pontine myelinolysis 1 (1.0) 0.04
Neuropathy 1 (1.0) 0.04
Intracranial infection 1 (1.0) 0.04
Cerebral edema 1 (1.0) 0.04
Subclinical status epilepticus 1 (1.0) 0.04
Leg twitching 1 (1.0) 0.04
Leg weakness 1 (1.0) 0.04
Viral myositis 1 (1.0) 0.04
Tinnitus 1 (1.0) 0.04
Posterior reversible
leukoencephalopathy
1 (1.0) 0.04
Table 3 | Univariate analysis of risk factors for neurologic
complications following OLT.
Variable OR 95% CI (p-value)
Medical comorbidity
Dialysis 2.11 0.80–2.40 (0.041)
Hepatorenal syndrome 2.9 0.87–2.91 (0.01)
Renal insufficiency 2.23 0.93–2.17 (0.006)
Preoperative conditions
Encephalopathy 1.97 0.86–2.09 (0.023)
Pressor use 2.72 0.71–3.36 (0.052)
Intubation 2.8 0.78–3.15 (0.028)
Infectiona 2.83 0.98–2.52 (0.002)
Intra-operative events
Dialysis 1.98 0.80–2.25 (0.046)
Variables with p<0.2 are included.
aSignificant on multivariate analysis.
exacerbating the potential for acquiring infection and developing
neurological complications post-operatively (11, 23).
In our analyses of hypothesis-generating risk factors for one-
month mortality after OLT, re-transplantation within the first
Table 4 | Univariate analysis of laboratory risk factors for neurologic
complications after OLT.
Variable Mortality group
(level±SD)
Survival group
(level±SD)
p-Value
MELD score 23.51±11.9 20.24±10.88 0.056
Hemoglobin (g/dL) 10.72±1.91 11.31±2.13 0.03
PTT (s) 39.13±10.64 36.23±8.49 0.026
INR (IU) 1.73±0.84 1.52±0.56 0.06
Number of intra-
operative pressors
1.36±0.66 1.15±0.75 0.027
OLT: orthotopic liver transplantation; MELD: Model for end-stage liver disease;
PTT: Partial thromboplastin time; INR: international normalized ratio. Laboratory
values with p<0.2 are included.
Table 5 | Characteristics of the 14 mortalities in the study population.
Number POD Cause of death Neurological
complication
1 2 Cardiogenic shock None
2 2 Sepsis Encephalopathy
3 4 Pulmonary embolism Stroke, Myoclonus
4 5 Cardiogenic shock None
5 5 Herniation Cerebral Edema
6 6 Cardiogenic shock Lower extremity
twitching
7 7 Cardiac arrest in later
surgery
None
8 12 Sepsis None
9 15 Cardiogenic shock None
10 19 Herniation Intracerebral
Hemorrhage
11 21 Intracerebral
hemorrhage
Intracerebral
Hemorrhage
12 26 Sepsis None
13 28 Asystole after seizure Intracerebral Infection,
Seizure
14 29 Sepsis None
POD, post-operative day.
month was independently associated with one-month mortality.
Urgent liver re-transplant is necessary when complications such
as primary non-function or vascular thrombosis cause the allo-
graft to fail (24). Our mortality rate of 50% in the first month
for acute re-transplant is comparable to other studies, which
cite a two-month mortality rate of 51% in patients who acutely
undergo re-transplantation (25). Urgent re-transplantation has
been shown to have much lower survival rates compared to
overall liver re-transplantations, and our results corroborate this
finding (26).
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Table 6 | Univariate analysis of risk factors for one-month mortality
following OLT.
Variable OR 95% CI (p-value)
Transplant type
Urgent re-transplant* 12.69 0.87–10.40 (0.003)
Non-urgent re-transplant 3.48 0.55–5.38 (0.094)
Medical comorbidity
Pre-existing neurologic disease 2.8 0.66–3.72 (0.071)
Recent surgery 7.56 0.46–12.54 (0.063)
Preoperative conditions
Pressor use 4.97 0.78–5.19 (0.013)
Intubationa 4.5 0.81–4.58 (0.011)
Infection 3.21 0.78–3.51 (0.021)
Intraoperative events
Arrhythmiaa 4.97 0.78–5.19 (0.013)
Cardiac arrest 55.19 1.00–32.63 (<0.001)
Hypotension 7.78 0.94–6.34 (0.002)
Race N/A N/A (0.169)
Variables with p<0.2 are included.
aSignificant on multivariate analysis.
Table 7 | Univariate analysis of laboratory risk factors of one-month
mortality following OLT.
Variable Mortality group
(level±SD)
Survival group
(level±SD)
p-Value
MELD score 24.75±10.59 21.47±11.42 0.181
Hemoglobin (g/dL) 9.94±1.45 11.1±2.09 0.024
PTT (s) 40.34±11.21 37.41±9.41 0.185
INR (IU) 1.99±1.3 1.6±0.7 0.151
Albumin (g/dL) 2.65±0.7 3.11±2.07 0.068
Number of intra-
operative pressors
1.95±1.1 1.19±0.68 0.001
OLT: orthotopic liver transplantation; MELD: Model for end-stage liver disease;
PTT: Partial thromboplastin time; INR: international normalized ratio. Laboratory
values with p<0.2 are included.
Pre-operative intubation also was an independent predictor
of one-month mortality, a finding that has not been reported in
prior studies of complications after OLT. One study has demon-
strated that among patients who underwent emergency or elective
living-donor liver transplantation (LDLT), those who underwent
emergency LDLT had higher rates of pre-operative intubation,
suggesting greater pre-transplant acuity and possibly poorer post-
transplant outcome (27). Further, intraoperative arrhythmias were
also independently associated with one-month mortality, corrob-
orating studies that have suggested patients with atrial fibrillation
may be at increased risk of mortality after liver transplantation
(28, 29). Despite these few reports, risk factors associated with
mortality after OLT have not been well characterized in the litera-
ture. Our results contribute to an improved understanding of the
risk factors for post-transplant mortality in a vulnerable patient
population.
While prior study populations were predominantly Caucasian,
our study population was predominantly Hispanic. Studies have
demonstrated poorer outcomes in minority populations, par-
ticularly African Americans (30). Some research has suggested
that liver transplantation among Hispanics has excellent out-
comes compared to non-Hispanics (31), while other studies
have highlighted suboptimal outcomes among minority popu-
lations, including greater mortality rates (31–34). Our results
demonstrated that African American and Hispanic patients had
greater mortality than Caucasian patients. Though no factors
were identified to explain these differences, possibilities include
immunologic and genetic differences between recipients and
donors.
The main limitation of this investigation is its retrospective
design. It is possible that not all neurological findings were doc-
umented in the patient charts, resulting in an underestimation of
some results. Our one-month follow-up may have missed neu-
rological complications that occurred later in the post-operative
course. Nevertheless, the findings contribute to a growing body
of literature that examines neurological complications after OLT
(12, 19, 28).
In summary, neurological complications after OLT are com-
mon in the post-MELD era, with encephalopathy being the most
common complication. Infection was independently associated
with the development of post-operative neurological complica-
tions, suggesting that these complications may be reduced by
treating infection during the preoperative period. In addition,
urgent re-transplant, preoperative intubation, and intraoperative
arrhythmias were independent predictors of one-month mortality
after OLT. Identifying hypothesis-generating risk factors for both
the development of neurological complications and one-month
mortality supports a better understanding of the population most
at risk for adverse outcomes after transplantation.
Future studies might investigate the role of infection in neu-
rological complications to better determine the pathophysiology
involved in conditions such as encephalopathy and ischemic stroke
among OLT patients. Similarly, factors this investigation revealed
to be associated with one-month mortality after OLT, such as intra-
operative arrhythmias, have been less well-characterized in the
literature and warrant further investigation to clarify their impact
on outcomes. An improved understanding of these hypothesis-
generating risk factors for neurological complications and one-
month mortality after liver transplantation ultimately may reduce
adverse outcomes and improve graft and patient survival.
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